(VIANEWS) – Teekay Tankers Ltd. (TNK), Southern Copper (SCCO), Northeast Bank (NBN) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Teekay Tankers Ltd. (TNK)
95.2% sales growth and 24.01% return on equity
Teekay Tankers Ltd. provides marine transportation services to oil industries in Bermuda and internationally. The company offers voyage and time charter services; and offshore ship-to-ship transfer services of commodities primarily crude oil and refined oil products, as well as liquid gases and various other products. It also provides tanker commercial and technical management services. As of December 31, 2021, the company owned and leased 48 double-hull oil tankers, time-chartered in two Aframax tankers, and one LR2 tanker. Teekay Tankers Ltd. was incorporated in 2007 and is headquartered in Hamilton, Canada.
Earnings Per Share
As for profitability, Teekay Tankers Ltd. has a trailing twelve months EPS of $6.27.
PE Ratio
Teekay Tankers Ltd. has a trailing twelve months price to earnings ratio of 6.01. Meaning, the purchaser of the share is investing $6.01 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.01%.
Moving Average
Teekay Tankers Ltd.’s value is way below its 50-day moving average of $42.36 and way above its 200-day moving average of $32.68.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Teekay Tankers Ltd.’s EBITDA is 9.89.
Sales Growth
Teekay Tankers Ltd.’s sales growth is 236.4% for the current quarter and 95.2% for the next.
Yearly Top and Bottom Value
Teekay Tankers Ltd.’s stock is valued at $37.67 at 16:23 EST, way below its 52-week high of $48.05 and way higher than its 52-week low of $14.24.
2. Southern Copper (SCCO)
31.3% sales growth and 32.62% return on equity
Against this backdrop, we suggest keeping a close eye on companies like Southern Copper Corporation (SCCO Quick QuoteSCCO – Free Report) , Freeport-McMoRan Inc. ((FCX Quick QuoteFCX – Free Report) ), Coeur Mining (CDE Quick QuoteCDE – Free Report) , Energy Fuels (UUUU Quick QuoteUUUU – Free Report) and Amerigo Resources (ARREF Quick QuoteARREF – Free Report) .
Southern Copper Corporation engages in mining, exploring, smelting, and refining copper and other minerals in Peru, Mexico, Argentina, Ecuador, and Chile. The company is involved in the mining, milling, and flotation of copper ore to produce copper and molybdenum concentrates; smelting of copper concentrates to produce blister and anode copper; refining of anode copper to produce copper cathodes; production of molybdenum concentrate and sulfuric acid; production of refined silver, gold, and other materials; and mining and processing of zinc, copper, molybdenum, silver, gold, and lead. It operates the Toquepala and Cuajone open-pit mines, and a smelter and refinery in Peru; and La Caridad, an open-pit copper mine, as well as a copper ore concentrator, a SX-EW plant, a smelter, refinery, and a rod plant in Mexico. The company also operates Buenavista, an open-pit copper mine, as well as two copper concentrators and two operating SX-EW plants in Mexico. In addition, it operates five underground mines that produce zinc, lead, copper, silver, and gold; a coal mine that produces coal and coke; and a zinc refinery. The company has interests in 493,117 hectares of exploration concessions in Peru and Mexico; 239,077 hectares of exploration concessions in Argentina; 30,568 hectares of exploration concessions in Chile; and 7,299 hectares of exploration concessions in Ecuador. Southern Copper Corporation was incorporated in 1952 and is based in Phoenix, Arizona. Southern Copper Corporation is a subsidiary of Americas Mining Corporation.
Earnings Per Share
As for profitability, Southern Copper has a trailing twelve months EPS of $3.44.
PE Ratio
Southern Copper has a trailing twelve months price to earnings ratio of 20.02. Meaning, the purchaser of the share is investing $20.02 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 32.62%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 1.1%, now sitting on 10.08B for the twelve trailing months.
3. Northeast Bank (NBN)
24.3% sales growth and 15.96% return on equity
Northeast Bank provides personal and business banking services in Maine, the United States. The company's deposit products include demand deposit, NOW, money market, savings, certificate of deposit, and individual retirement accounts, as well as checking accounts. Its loan portfolio comprises residential mortgage loans; multi-family and other commercial real estate loans; commercial and industrial loans, such as term loans, lines of credit and equipment, and receivables financing; consumer loans comprising mobile home and overdraft, and deposit-secured loans; and small business administration loans. In addition, the company offers telephone banking, online banking and bill payment, mobile banking, cash management, and remote deposit capture services, as well as debit and credit card, ATM, electronic transfer, and check services. It operates a network of nine branches in Western, Central, and Southern Maine. Northeast Bank was founded in 1872 and is headquartered in Portland, Maine.
Earnings Per Share
As for profitability, Northeast Bank has a trailing twelve months EPS of $5.36.
PE Ratio
Northeast Bank has a trailing twelve months price to earnings ratio of 6.8. Meaning, the purchaser of the share is investing $6.8 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.96%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on May 3, 2023, the estimated forward annual dividend rate is 0.04 and the estimated forward annual dividend yield is 0.11%.
4. Webster Financial Corporation (WBS)
13.9% sales growth and 10.71% return on equity
Webster Financial Corporation operates as the bank holding company for Webster Bank, National Association that provides a range of banking, investment, and financial services to individuals, families, and businesses in the United States. It operates through three segments: Commercial Banking, HSA Bank, and Community Banking. The Commercial Banking segment provides lending, deposit, and cash management services to middle market companies; and commercial and industrial lending and leasing, commercial real estate lending, equipment financing, and asset-based lending, as well as treasury and payment services. This segment also offers asset management, financial planning and trust services, and deposit and loan products for high net worth clients, not-for-profit organizations, and business clients. The HSA Bank segment offers health savings accounts, health reimbursement accounts, flexible spending accounts, and other financial solutions to employers for the benefit of their employees and individuals. The Community Banking segment offers deposit and fee-based services, residential mortgages, home equity lines or loans, unsecured consumer loans, and credit cards to consumers, as well as investment and securities-related services, including brokerage and investment advice through a strategic partnership with LPL Financial Holdings Inc. This segment also provides credit, deposit, and cash flow management products to businesses and professional service firms. The company also offers online and mobile banking services. As of February 12, 2021, it operated 155 banking centers and 297 ATMs. Webster Financial Corporation was founded in 1935 and is headquartered in Waterbury, Connecticut.
Earnings Per Share
As for profitability, Webster Financial Corporation has a trailing twelve months EPS of $5.1.
PE Ratio
Webster Financial Corporation has a trailing twelve months price to earnings ratio of 6.65. Meaning, the purchaser of the share is investing $6.65 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.71%.
5. Semler Scientific (SMLR)
8.2% sales growth and 28.3% return on equity
Semler Scientific, Inc. develops, manufactures, and markets proprietary products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups. The company offers its products through salespersons and distributors. Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California.
Earnings Per Share
As for profitability, Semler Scientific has a trailing twelve months EPS of $1.71.
PE Ratio
Semler Scientific has a trailing twelve months price to earnings ratio of 16.19. Meaning, the purchaser of the share is investing $16.19 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.3%.
6. Globus Medical (GMED)
6.6% sales growth and 10.6% return on equity
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Earnings Per Share
As for profitability, Globus Medical has a trailing twelve months EPS of $1.85.
PE Ratio
Globus Medical has a trailing twelve months price to earnings ratio of 30.53. Meaning, the purchaser of the share is investing $30.53 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.6%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 9.8%, now sitting on 1.02B for the twelve trailing months.
Sales Growth
Globus Medical’s sales growth is 10.6% for the current quarter and 6.6% for the next.
Previous days news about Globus Medical(GMED)
- Globus medical's (gmed) reflect correction system gets FDA nod. According to Zacks on Tuesday, 16 May, "Since REFLECT has been offered worldwide for several years, Globus Medical is thrilled to provide this system to patients in the United States. "
7. Balchem Corporation (BCPC)
6.4% sales growth and 10.73% return on equity
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.
Earnings Per Share
As for profitability, Balchem Corporation has a trailing twelve months EPS of $3.06.
PE Ratio
Balchem Corporation has a trailing twelve months price to earnings ratio of 41.98. Meaning, the purchaser of the share is investing $41.98 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.73%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Balchem Corporation’s EBITDA is 4.9.
Volume
Today’s last reported volume for Balchem Corporation is 81832 which is 11.34% below its average volume of 92300.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Dec 22, 2022, the estimated forward annual dividend rate is 0.71 and the estimated forward annual dividend yield is 0.55%.
8. Sprouts Farmers Market (SFM)
5.9% sales growth and 24.14% return on equity
Sprouts Farmers Market, Inc. offers fresh, natural, and organic food products in the United States. The company offers perishable product categories, including fresh produce, meat, seafood, deli, bakery, floral and dairy, and dairy alternatives; and non-perishable product categories, such as grocery, vitamins and supplements, bulk items, frozen foods, beer and wine, and natural health and body care. As of January 2, 2022, it operated 374 stores in 23 states. Sprouts Farmers Market, Inc. was founded in 2002 and is headquartered in Phoenix, Arizona.
Earnings Per Share
As for profitability, Sprouts Farmers Market has a trailing twelve months EPS of $2.33.
PE Ratio
Sprouts Farmers Market has a trailing twelve months price to earnings ratio of 15.68. Meaning, the purchaser of the share is investing $15.68 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.14%.
Volume
Today’s last reported volume for Sprouts Farmers Market is 1219720 which is 26.37% below its average volume of 1656710.
Sales Growth
Sprouts Farmers Market’s sales growth is 5.7% for the ongoing quarter and 5.9% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Sprouts Farmers Market’s EBITDA is 0.75.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 12.3% and 1.6%, respectively.
